from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0885/-

LFCtreatmentdescriptionclass of inhibitor

1.579

Amikacinug/mL Amikacintranslation

1.611

Cap5-10ug/mL Capreomycintranslation

2.253

Rox10-50 ug/mL Roxithromycintranslation

-0.243

SM2-5 ug/mL Streptomycintranslation

1.700

Tet5-10 ug/mL Tetracyclinetranslation

-0.335

Rif0.2-5ug/mL Rifampicintranscription

-0.228

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.690

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.404

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.090

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.027

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.575

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.416

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.378

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.524

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.648

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.110

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.081

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.077

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.104

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.594

KCN5-20 ug/mL Potassium cyaniderespiration

-0.568

NaN30.2-2 mM Sodium aziderespiration

0.041

Nigericin50 uM Nigericinrespiration

-0.023

TRC10-150 ug/mL Triclosanrespiration

0.279

TRZ10-25 ug/mL Thioridazinerespiration

0.745

Valinomycin0.5-10 uM Valinomycinrespiration

-1.247

ZnSO42 mM ZnSO4respiration

-1.295

menadione6-10 ug/mL Menadionerespiration

2.882

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.331

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.416

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.264

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.253

NRP_1Non-replicating persistence stage 1dosRassociated

-0.550

Amp0.2mg/mL AmpicillincellWall

-0.328

Cephalexin20-100 ug/mL CephalexincellWall

-0.792

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.472

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.035

EMB10-20 ug/mL EthambutolcellWall

1.444

Eta12-40 ug/mL EthionamidecellWall

1.397

INH0.2-0.4 ug/mL IsoniazidcellWall

0.958

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.628

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.733

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.494

BZA0.12 mg/mL BenzamidearomaticAmides

-0.604

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.154

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.228

H2O24 mM hydrogen peroxideDNAdamaging

-0.342

Levo10 ug/mL LevofloxacinDNAdamaging

-0.514

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.926

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.162

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.269

UVUV-irradiationDNAdamaging

-1.197

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.796

Antimycin12.5-50 ug/mL Antimycin A?

-0.338

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.064

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.060

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.635

PA8240.2-2 ug/mL PA-824?

1.199

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.481

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.423

Verapamil50 uM Verapamil?

-0.679

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.640

methoxatin10-20 ug/mL Methoxatin?